Singapore studying effectiveness and safety of Moderna, Pfizer-BioNTech’s Covid-19 vaccines for children 6 months and older
The study will look at the use of Moderna's Covid-19 vaccine for children aged six months to five years, and Pfizer-BioNTech's vaccine for those aged six months to four years.
The vaccine from both bio-pharmaceutical brands uses messenger ribonucleic acid (mRNA) to set up an immune system response to fight infection rather than part of an inactivated virus.
The US Centers for Disease Control and Prevention last Saturday recommended Covid-19 vaccines for children as young as six months, allowing a nationwide rollout to start next week. The US CDC's move came after a panel of advisers voted to recommend Covid-19 vaccines for this group of children.